Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Omega Therapeutics
Biotech
Omega halts sole clinical-stage asset to focus on 3 programs
Omega is halting work on its clinical-stage candidate as part of a strategic refocus centered on three preclinical epigenomic controller programs.
James Waldron
Nov 15, 2024 5:33am
Roche, Vir, Neurocrine & more—Chutes & Ladders
May 31, 2024 8:30am
Novo Nordisk inks obesity, MASH pacts with 2 Flagship biotechs
Jan 4, 2024 7:34am
Omega taps Stanford to find targets for genome-tuning tech
Oct 14, 2021 9:05am
Outsmarting cancer with RNA and other gene-altering therapies
Jun 28, 2021 5:00pm
Omega grabs $126M to bring 'genome-tuning' program into clinic
Mar 30, 2021 7:00am
